New mRNA Flu Vaccine Approved: Boosting Protection Against Flu, COVID-19, and RSV

September 16, 2026
New mRNA Flu Vaccine Approved: Boosting Protection Against Flu, COVID-19, and RSV
  • Vaccination is the best defense against severe illness from flu, COVID-19, and RSV, with priority emphasis on older adults, pregnant people, and young infants, while vaccines can benefit a broader population.

  • The flu season typically peaks December through February, with activity possible from October to April and varying by locality.

  • Florida residents will gain access to Moderna’s new mRNA flu vaccine, mFLUSIVA, at select pharmacies soon, with wider availability rolling out through the fall after FDA lot releases.

  • Healthcare data show a stagnant national test positivity rate but reveal regional disparities, notably higher positivity in Texas and neighboring states in the South and West.

  • Note: EIN Presswire provides content as is and does not guarantee accuracy; readers should contact the author for copyright questions.

  • Laredo uses wastewater surveillance to track trends, even though COVID-19 is no longer a reportable disease in Texas.

  • The summer wave likely had fewer cases than previous summers, but comparing wastewater data remains uncertain due to evolving virus dynamics and data interpretation.

  • COVID-19 activity is rising as the respiratory season begins, with wastewater signaling high nationwide levels and a sharp post-summer uptick.

  • CDC estimated infections are rising in 27 states, with 13 declining and 10 unchanged, reflecting regional variation in waves.

  • Despite overall low national viral activity in wastewater, several Southern and Western states report moderate to very high activity levels.

  • A formal note from the U.S. health system discusses behind-the-scenes guidance and oversight for vaccine-related reviews and public communications.

  • The West Coast Health Alliance, spanning California, Hawaii, Oregon, and Washington, aims to guide public health recommendations with safety, efficacy, transparency, access, and trust.

Summary based on 71 sources


Get a daily email with more World News stories

More Stories